|
Updated section h6- type of investigation, findings, and conclusions.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The device was not returned for evaluation as it was discarded.The provided 3mensio imagery was reviewed, and the following was observed: in the comments section: "tf access does not meet minimum diameters.Carotid access appears consistent on the rt." tortuosity, calcification, and undersized vessel diameters (<5mm) were present in the left access vessel, near the aortic bifurcation and iliac.The 14f esheath+ is indicated for use with vessel diameters greater than or equal to 5.5mm.The complaints about the inability to track system through anatomy and valve dislodged off balloon during withdrawal through sheath are unable to be confirmed as no device or relevant imagery was provided for evaluation.As the device was not returned, engineering was unable to perform any visual examination, functional testing, or dimensional analysis.Therefore, the presence of a manufacturing non-conformance was unable to be determined.A review of the dhr did not provide any indication that a manufacturing non-conformance would have contributed to the complaint event.A review of the ifu/training materials revealed no deficiencies.Furthermore, no abnormalities were reported during device unpacking or preparation.Per review of the 3mensio that was provided, tortuosity, calcification, and undersized vessel diameters (<5mm) were observed within the left access vessel, near the aortic bifurcation and the iliac.The 14f esheath+ is indicated for use with vessel diameters greater than or equal to 5.5mm.Per the training manual, "push force can vary due to angle of access and insertion, thv size, vessel diameter, tortuosity and degree of calcification." in this case, it was reported that the commander delivery system would not pass the aortic bifurcation, and the delivery system was outside of the sheath, suggesting that the sheath was not fully inserted past the aortic bifurcation.Additionally, 3mensio revealed calcified, tortuous, and under-sized access vasculature.Edwards training manuals caution "the thv should not be advanced through the sheath if the sheath tip is not past the aortic bifurcation".Patient factors (i.E.Calcification, tortuosity, small vessel size) may cause constrained sections of the anatomy that interfere with passage of the sheath and/or delivery system with thv and cause difficulty during tracking.As such, available information suggests that patient factors (undersized vessel, calcification, tortuosity) and/or procedural factors (sheath not advanced past aortic bifurcation) may have contributed to the inability to track the system through anatomy.Patient factors (tortuosity, calcification, undersized vessels), as observed in patient 3mensio, can lead to noncoaxial withdrawal angle, causing the crimped valve to be caught on the sheath tip during retrieval and lead to resistance during withdrawal.Additional device manipulation to overcome the withdrawal difficulties can dislodge the valve from the balloon, as reported.As such, available information suggests that patient factors (undersized vessel, calcification, tortuosity) and/or procedural factors (non-coaxial withdrawal, device manipulation) may have contributed to the valve dislodged off balloon during withdrawal through sheath.However, a definitive root cause is unable to be determined at this time.Complaint histories for all reported events are reviewed against trending control limits on a monthly basis, and any excursions above the control limits are assessed and documented as part of this monthly review.Since no edwards product defects or labeling deficiencies were identified, no corrective or preventative action is required.
|